CHEMOPREVENTION FOR PROSTATE CANCER IN PATIENTS WITH BENIGN PROSTATE HYPERPLASIA WITH ELEVATED PROSTATE-SPECIFIC ANTIGEN LEVELS
<p>The paper gives the comparative results of chemoprevention against prostate cancer (PC) in 189 patients with benign prostate hyperplasia with a prostate-specific antigen (PSA) level of 2.5 to 10.0 ng/ml during 4‑year combined (avodart + omnic) or monotherapy with either drug. Biopsy reveale...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2014-07-01
|
| Series: | Onkourologiâ |
| Subjects: | |
| Online Access: | http://oncourology.abvpress.ru/index.php/oncur/article/view/139 |